These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32851922)

  • 21. Apparent resistant hypertension and the risk of vascular events and mortality in patients with manifest vascular disease.
    van der Sande NGC; de Beus E; Bots ML; Voskuil M; Blankestijn PJ; Visseren F; Spiering W;
    J Hypertens; 2018 Jan; 36(1):143-150. PubMed ID: 28763342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.
    Muxfeldt ES; Margallo V; Costa LM; Guimarães G; Cavalcante AH; Azevedo JC; de Souza F; Cardoso CR; Salles GF
    Hypertension; 2015 Apr; 65(4):736-42. PubMed ID: 25601933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study.
    Feng Z; Li Y; Wang C; Tian L; Yao S; Wang M; Zhao M; Lan L; Wu S; Xue H
    J Clin Hypertens (Greenwich); 2024 Jun; 26(6):714-723. PubMed ID: 38651799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.
    Clement DL; De Buyzere ML; De Bacquer DA; de Leeuw PW; Duprez DA; Fagard RH; Gheeraert PJ; Missault LH; Braun JJ; Six RO; Van Der Niepen P; O'Brien E;
    N Engl J Med; 2003 Jun; 348(24):2407-15. PubMed ID: 12802026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Changes in Aortic Stiffness for Cardiovascular Outcomes and Mortality in Resistant Hypertension: a Cohort Study.
    Cardoso CRL; Salles GF
    Hypertension; 2022 Feb; 79(2):447-456. PubMed ID: 35020459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice.
    Fagard RH; Van Den Broeke C; De Cort P
    J Hum Hypertens; 2005 Oct; 19(10):801-7. PubMed ID: 15959536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and clinical profile of refractory hypertension in a large cohort of patients with resistant hypertension.
    Chedier B; Cortez AF; Roderjan CN; Cavalcanti AH; Carlos FOC; Dos Santos BDM; Muxfeldt ES
    J Hum Hypertens; 2021 Aug; 35(8):709-717. PubMed ID: 32868882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
    Sleep Med Rev; 2017 Jun; 33():17-27. PubMed ID: 27316324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
    JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea.
    Kwon CH; Kim W; Shin JH; Lee CJ; Kim HC; Kang SH; Jung MH; Kim DH; Lee JH; Kim HL; Kim HM; Cho IJ; Cho I; Kang DR; Lee HY; Chung WJ; Ihm SH; Kim KI; Cho EJ; Sohn IS; Park S; Shin J; Ryu SK; Kang SM; Cho MC; Kim JH; Lee JH; Kim JY; Pyun WB; Sung KC
    J Am Heart Assoc; 2021 Apr; 10(7):e017890. PubMed ID: 33739126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.
    de Souza F; Muxfeldt ES; Salles GF
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):735-45. PubMed ID: 22894630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is It All that Matters?
    Cardoso CR; Salles GF
    Curr Hypertens Rep; 2016 Dec; 18(12):85. PubMed ID: 27837396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood Pressure Classification of 2017 Associated With Cardiovascular Disease and Mortality in Young Chinese Adults.
    Wu S; Song Y; Chen S; Zheng M; Ma Y; Cui L; Jonas JB
    Hypertension; 2020 Jul; 76(1):251-258. PubMed ID: 32520626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk with and without antihypertensive drug treatment in the Japanese general population: participant-level meta-analysis.
    Asayama K; Satoh M; Murakami Y; Ohkubo T; Nagasawa SY; Tsuji I; Nakayama T; Okayama A; Miura K; Imai Y; Ueshima H; Okamura T;
    Hypertension; 2014 Jun; 63(6):1189-97. PubMed ID: 24637661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of the nocturnal blood pressure fall and morning surge with cardiovascular events and mortality in individuals with resistant hypertension.
    Cardoso CRL; Salles GF
    J Hypertens; 2021 Jun; 39(6):1177-1187. PubMed ID: 33427790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
    J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.
    Zanchetti A; Hansson L; Dahlöf B; Elmfeldt D; Kjeldsen S; Kolloch R; Larochelle P; McInnes GT; Mallion JM; Ruilope L; Wedel H
    J Hypertens; 2001 Jun; 19(6):1149-59. PubMed ID: 11403365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.